Home › NDC Lookup › Ingredients › Ivermectin › 87782-0001-02
SYNTHABIO Ivermectin .5 g/100g Lotion — NDC 87782-0001-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

SYNTHABIO Ivermectin .5 g/100g Lotion — NDC 87782-001-02 (Billing 87782-0001-02)

by Shenzhen Xuyan Technology Co., Ltd. · 1 TUBE in 1 BOX / 117 g in 1 TUBE

This is a package of SYNTHABIO Ivermectin .5 g/100g Lotion from Shenzhen Xuyan Technology Co., Ltd., marketed since Jun 2026 and currently FDA-listed. It is this product's only package size.

NDC 87782-0001-02
🏷️ FDA NDC (as labeled) 87782-001-02 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 87782-001-02 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
87782 labeler · 001 product · 02 package
Package marketed since
Jun 12, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC)
7239079599280
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87782-001-02
Product NDC 87782-001
11-digit billing NDC 87782000102
RxCUI 1246673
UNII 8883YP2R6D
UPC 7239079599280
Application # M024
SPL Set ID 540d6a24-68bf-50c8-e063-6294a90aaa30
Established class (EPC) Antiparasitic; Pediculicide
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-06-12
Route TOPICAL
Dosage form LOTION
Substance IVERMECTIN
Quick answers
  • RxCUI (RxNorm): 1246673
Why two NDCs? The FDA registers this code as 87782-001-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87782-0001-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiparasitic class.

Pharmacologic class Antiparasitic, Pediculicide
Drug family (ATC) Other dermatologicals, Avermectines
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Ivermectin lotion is used to treat head lice (small bugs that attach themselves to the skin) in adults and children 6 months of age and older. Ivermectin is in a class of medications called anthelmintics. It works by killing lice.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Tablets treat intestinal strongyloidiasis and onchocerciasis. Lotions treat head lice, and the cream treats the bumps and pimples of rosacea.
  • Stromectol and ivermectin tablets are usually a single dose based on your weight. Take it on an empty stomach with water. Your doctor may order follow-up stool tests to confirm the...
  • Apply it to dry hair and scalp, covering everything from the scalp outward. Leave it on for 10 minutes, then rinse with water only. Wait 24 hours before shampooing, and don't reuse...
  • Dizziness, itching, rash, nausea, diarrhea, and tiredness were reported. If you're treated for onchocerciasis, fever, swollen glands, and joint pain can happen as the parasites die...
📖 Read our full Ivermectin guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87782-0001-02 You're viewing this Main listing 1 TUBE in 1 BOX / 117 g in 1 TUBE 2026-06-12 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sklice 5 mg/g 24338-0185-04 Azurity 1 tube $0.285 — Availability likely —
Ivermectin 5 mg/g 51672-4230-08 Sun 1 tube $1.239 — Availability likely —
Ivermectin 5 mg/g 00363-4230-08 Walgreen 1 tube — — FDA listed —
Ivermectin 5 mg/g 11822-4230-08 Rite 1 tube — — FDA listed —
Ivermectin 5 mg/g 27854-0334-01 Belmora 1 tube — — FDA listed —
Ivermectin 5 mg/g 46122-0827-36 AmerisourceBergen 1 tube — — FDA listed —
Ivermectin 5 mg/g 51316-0423-08 CVS 1 tube — — FDA listed —
Ivermectin 5 mg/g 51316-0985-08 CVS 1 tube — — FDA listed —
Ivermectin 5 mg/g 79903-0154-01 WALMART 1 tube — — FDA listed —
RID One and Done 5 mg/g 82392-0200-04 Oystershell 1 tube — — FDA listed —
lice treatment dedicated .5 g/100g 87276-0000-01 Shenzhen 1 g — — FDA listed —
lice treatment dedicated .5 g/100g 87276-0001-01 Shenzhen 1 g — — Discontinued —
ivometn ivermectin lice treatment .5 g/100g 87276-0003-01 Shenzhen 1 g — — FDA listed —
SYNTHABIO Ivermectin .5 g/100gthis 87782-0001-02 Shenzhen 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jun 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerShenzhen Xuyan Technology Co., Ltd.
FDA applicationM024 (OTC MONOGRAPH DRUG)
Labeler code87782
First marketedJun 2026
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage ~1 min read ▾

Important: Read warnings before use Age supervision: Children 6 months to under 12 years: an adult should supervise use. Adults and children 6 months and over: use as directed. Inspect: Have another person check all household members for lice and/or nits (eggs).

Use a comb or two unsharpened pencils to lift and part the hair. Look for tiny nits near the scalp, beginning at the back of the neck and behind the ears. Examine small sections of hair (1–2 inches wide) at a time.

Unlike dandruff, nits stick to the hair. Dandruff moves when lightly touched. If lice or nits are found, treat with this product.

Treat: Hair and scalp must be dry before applying product. Use the top of the cap to break the tamper seal on the tube. Apply product directly to dry hair and scalp.

Wait and rinse: Leave product on hair and scalp for 10 minutes after application. Use a timer or clock. Start timing after you have completely covered your hair and scalp.

After 10 minutes, rinse product completely from hair and scalp using only water. After rinsing, dry and style as usual. Wait 24 hours before applying shampoo.

After treatment: Wash hands after applying the product. Not combing is not necessary for the product to work. If desired, use a fine-tooth comb or special nit comb to remove dead lice and nits.

This is a single-use product. Discard tube after use. Do not use again on the same person for the same lice infestation without talking to a healthcare provider first.

If infestation continues, see a doctor for other treatments. Machine wash any bedding and clothing used by anyone with lice. Wash at high temperature (150°F) and tumble in a hot dryer for 20 minutes.

After finishing treatment, check everyone in your family for lice after one week. Consider treatment for those who have lice.

⏱️ Dosage and Administration 3 words ▾

Treats head lice

⚠️ Warnings 9 words ▾

For external use only. Use only on the scalp.

🧪 Active Ingredient 2 words ▾

Ivermectin 0.5%

🧪 Inactive Ingredients 30 words ▾

Butylated hydroxyanisole, castor oil, cetyl alcohol, cyclomethicone, glycerin, imidurea, lanolin alcohols, methylparaben, oleyl alcohol, olive oil, propylene glycol, propylparaben, purified water, shea butter, sodium citrate anhydrous, sorbitan tristearate, stearyl alcohol.

🎯 Purpose 2 words ▾

Lice treatment

📄 Do Not Use 33 words ▾

on children under 6 months of age near the eyes inside the nose, ear, mouth, or vagina on lice in eyebrows or eyelashes (see a doctor if lice are present in these areas)

📄 Ask a Doctor Before Use If 51 words ▾

Ask a doctor before use if you: have any skin conditions or sensitivities are pregnant or plan to become pregnant (it is not known if this product can harm your unborn baby) are currently breastfeeding or plan to breastfeed (avoid getting product on your breast to prevent contact by your baby)

📄 When Using This Product 36 words ▾

Keep your eyes tightly closed and protect yourself with a washcloth or towel If product gets into eyes, gently flush with water Eye redness or irritation may occur Dandruff, dry skin, or burning sensation may occur

📄 Stop Use and Ask a Doctor If 16 words ▾

breathing difficulty occurs eye irritation occurs skin or scalp irritation continues, or infection occurs rash develops

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children

📄 Package Label / Principal Display Panel 1 words ▾

1

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for IVermectin (matched by generic name) — the program that covers self-administered drugs. 7 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name IVermectin. CMS lists 3 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.22M
Claims incl. refills
25.2K
Beneficiaries
20.3K
Spend / beneficiary
$158.78
Spend / claim
$128.08
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Shenzhen Xuyan Technology Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Shenzhen Xuyan Technology Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87781-0003-01 · Foshan 87785-0001-01 · Jinhua →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.